期刊文献+

抑癌基因PML在宫颈病变组织中的突变探讨 被引量:2

A study of tumor suppressor gene PML mutation in cervical lesions
下载PDF
导出
摘要 目的探讨抑癌基因早幼粒细胞性白血病基因(PML)在宫颈病变组织中是否存在突变。方法随机选取以下宫颈病变新鲜组织标本,包括宫颈上皮内瘤样病变I级(CINⅠ)、CINⅡ、CINⅢ、宫颈浸润鳞癌各30例、以及因其他疾病切除子宫病理证实为慢性宫颈炎者30例。用变性高效液相色谱(DHPLC)进行PML基因全部外显子及内含子-外显子交接区突变的筛查,对其中10例宫颈浸润鳞癌组织进行PML基因全部外显子及内含子-外显子交接区测序。结果全部组织均未发现PML基因突变。结论 PML在蛋白质水平的表达改变不是由其基因突变所引起。 Objective To study whether the tumor suppressor gene PML exists mutations in cervical lesions.Methods The following fresh tissue samples of cervical lesions were randomly selected,including 30 cases of CIN Ⅰ,CIN Ⅱ,CIN Ⅲ and cervical infiltrating squamous cell carcinoma respectively and 30 cases of chronic cervicitis.DHPLC was used to screen the PML exons and exon-intron boundaries for point mutations.We did PML exons and exon-intron boundaries direct sequencing for 10 cases of cervical infiltrating squamous cell carcinoma.Results We didn′t find any PML gene mutation in all samples.Conclusion PML expression change in protein level is not caused by the genetic mutation.
出处 《实用临床医药杂志》 CAS 2011年第11期77-79,共3页 Journal of Clinical Medicine in Practice
关键词 抑癌基因 早幼粒细胞性白血病基因 宫颈病变 基因突变 tumor suppressor gene PML cervical lesions genetic mutation
  • 相关文献

参考文献9

  • 1Vizcaino A P, Moreno V, Bosch F X, et aL. International trends incidence of cervical cancer: SquarnousceLL carcinoma [J]. Int J Cancer, 2002(3), 86: 429.
  • 2Einstein M H, GoLdberg G L. Human papiLLomavirus and cervical neopLasia[JJ. Cancer Invest, 2002, 20: 1080.
  • 3Munoz N, Bosch F X, DeSanjose S, et al. EpidemioLogic classification of human papiLLonmvirus typesassociated with cervical cancer[J]. N EngL J Med, 2003, 348: 489.
  • 4Lars C H, Georgios R. FamiLiaL cancer history in patients with carcinoma of the cervix uteri [ J ]. Eur J Obstet GynoL Reprod BioL, 2002, 101: 54.
  • 5Zhong S, SaLomoni P, ParndoLfi P P. The transcriptional. roLe of PML and the nuclear body [J]. Nat CeLl. BioL, 2000, 2: E85.
  • 6SaI.omoni P, PandoLfi P P. The roLe of PML in tumor suppression[J ]. CELL, 2002,108 : 165.
  • 7Gurrieri C, Calpodieci P, Bernardi R, et al. Loss of the tumor suppressor PML in human cancers of muLtipLe histoLogic ori gins[J]. J NatL Cancer lnst, 2004, 96(4): 269.
  • 8Gambaeorta M, FLenghi L, FagioLi M, et al. Heterogeneous nucLear expresskm of the promyeLocyticLeukemia (PML) protein in normal and neoplastic human tissues [ J ]. Am J PathoL, 1996, 149: 2023.
  • 9Szcndefi M, WaLt H, Krasieva T B, et al. Asaciation be tween promyeLocyte protein and smaLLubiquitin- Like modi tier protein and the progression of cervicaL neopLasia[J]. Ob stet GynecoL, 2003, 102: 1269.

同被引文献17

  • 1赵志龙,宗志红,李建新,刘宏旭,赵惠儒.从石蜡包埋肺癌组织提取RNA检测PML基因转录的研究[J].中国肺癌杂志,2008,11(4):563-566. 被引量:6
  • 2Lane AA,Ley TJ.Neutrophil elastase cleaves PML-RARαandis important for the development of acute promyelocyticleukemia in mice[J].Cell,2003,115(3):305-318.
  • 3Leung D.Adenoviridae:gene therapy and the molecular bio-logy of the adenovirus[J].Meducator,2012,1(1):15-16.
  • 4Luo JY,Deng ZL,Luo XJ,et al.A protocol for rapidgeneration of recombinant adeoviruses using the AdEasysystem[J].Nat Protoc,2007,2(5):1236-1247.
  • 5Jensen K,Shiels C,Freemont PS.PML protein isoforms andthe RBCC/TRIM motif[J].Oncogene,2001,20(49):7223-7233.
  • 6Krieghoff-Henning E,Hofmann TG.Role of nuclear bodies inapoptosis signaling[J].Biochim Biophys Acta,2008,1783(11):2185-2194.
  • 7Bernardi R,Papa A,Pandolfi PP.Regulation of apoptosis byPML and the PML-NBs[J].Oncogene,2008,27(48):6299-6312.
  • 8Salomoni P,Bernardi R,Bergmann S,et al.The promyelocyticleukemia protein PML regulates c-Jun function in response toDNA damage[J].Blood,2005,105(9):3686-3690.
  • 9Everett RD,Chelbi-Alix MK.PML and PML nuclear bodies:implications in antiviral defence[J].Biochimie,2007,89(6-7):819-830.
  • 10Shima Y,Shima T,Chiba T,et al.PML activates transcriptionby protecting HIPK2 and p300 from SCFFbx3-mediateddegradation[J].Mol Cell Biol,2008,28(23):7126-7138.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部